James W. Jacobberger
Affiliations: | Case Western Reserve University, Cleveland Heights, OH, United States |
Area:
Cell BiologyGoogle:
"James Jacobberger"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Montano MM, Yeh IJ, Chen Y, et al. (2019) Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells. Breast Cancer Research : Bcr. 21: 138 |
| Jacobberger JW, Sramkoski RM, Stefan T, et al. (2018) Multiparameter Cell Cycle Analysis. Methods in Molecular Biology (Clifton, N.J.). 1678: 203-247 |
| William BM, Brillhart K, Afable M, et al. (2018) A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Blood. 132: 1875-1875 |
| Molokie R, Lavelle D, Gowhari M, et al. (2017) Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. Plos Medicine. 14: e1002382 |
| Han X, Mayca Pozo F, Wisotsky JN, et al. (2015) Phosphorylation of Minichromosome Maintenance 3 (MCM3) by Checkpoint Kinase 1 (Chk1) Negatively Regulates DNA Replication and Checkpoint Activation. The Journal of Biological Chemistry. 290: 12370-8 |
| Han X, Zhang L, Chung J, et al. (2014) UbcH7 regulates 53BP1 stability and DSB repair. Proceedings of the National Academy of Sciences of the United States of America. 111: 17456-61 |
| Weis MC, Avva J, Jacobberger JW, et al. (2014) A data-driven, mathematical model of mammalian cell cycle regulation. Plos One. 9: e97130 |
| Huang Y, Sramkoski RM, Jacobberger JW. (2013) The kinetics of G2 and M transitions regulated by B cyclins. Plos One. 8: e80861 |
| Avva J, Weis MC, Sramkoski RM, et al. (2012) Dynamic expression profiles from static cytometry data: component fitting and conversion to relative, "same scale" values. Plos One. 7: e38275 |
| Bose P, Perkins EB, Honeycut C, et al. (2012) Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies. Cancer Chemotherapy and Pharmacology. 69: 1657-67 |